Overview
Ataxin refers to a family of proteins implicated in spinocerebellar ataxia (SCA), a group of hereditary neurodegenerative diseases. The most studied variants, Ataxin-1 and Ataxin-3, contain polyglutamine tracts whose abnormal expansion triggers protein aggregation and neuronal dysfunction. These proteins are critical for understanding the mechanisms of neurodegeneration and developing targeted therapies. Research on ataxins has revealed their roles in transcriptional regulation (Ataxin-1) and protein degradation (Ataxin-3). Mutations lead to toxic gain-of-function effects, disrupting cellular homeostasis. Studies often focus on Drosophila and mouse models to elucidate disease pathways and test potential interventions.
Key Features
Ataxins are characterized by their polyglutamine (polyQ) regions, which, when expanded beyond a threshold (e.g., >40 repeats in Ataxin-3), induce misfolding and aggregation. These aggregates form nuclear inclusions, a hallmark of SCA pathology. Normal ataxins participate in RNA processing (Ataxin-1) and ubiquitin-mediated proteolysis (Ataxin-3). The proteins' modular domains, such as the Josephin domain in Ataxin-3, confer specific enzymatic activities. Pathogenic forms lose native functions while acquiring cytotoxic properties. Researchers leverage these features to design small-molecule inhibitors or gene-silencing therapies aimed at mitigating aggregation.
Application Areas
Ataxin research spans basic science and clinical applications. In neuroscience, it provides insights into protein misfolding disorders like Huntington’s disease. Biotech firms develop diagnostic tools, such as PCR-based assays for polyQ expansion detection, aiding genetic counseling. Therapeutic strategies under investigation include antisense oligonucleotides (ASOs) to suppress mutant ataxin expression and chaperone proteins to prevent aggregation. Collaborative projects between academia and pharmaceutical companies aim to translate these findings into treatments, with several compounds in preclinical trials.
Precautions
Handling ataxin-related materials requires biosafety compliance, especially when working with viral vectors for gene delivery. Researchers should use appropriate personal protective equipment (PPE) and containment procedures. For families with SCA history, genetic testing must be accompanied by counseling to address ethical and psychological implications. Clinicians emphasize the importance of multidisciplinary care, including physical therapy and symptom management, as current treatments are primarily supportive.
B2B Procurement Guide
When sourcing ataxin antibodies or recombinant proteins for research, prioritize suppliers with validated specificity data (e.g., Western blot/immunofluorescence references). Reputable vendors include Sigma-Aldrich, Abcam, and Thermo Fisher Scientific. For high-throughput screening projects, consider contract research organizations (CROs) specializing in neurodegenerative disease models. Bulk orders of CRISPR/Cas9 kits for ataxin gene editing may qualify for academic discounts. Always review batch-to-batch consistency and technical support options.
Related Manufacturers
- 主营：牛骨胶、胶黏剂、工业明胶、电镀光亮剂、提炼胶颗粒、增稠高粘度骨胶
- 主营：工业骨胶、工业明胶、牛胶、工业蛋白、蛋白粉、骨胶粉、明胶、皮胶、骨胶、牛胶粉、工业胶、水胶、牛骨胶、小颗粒胶、动物胶
- 主营：胶黏剂、牛皮胶、工业明胶、工业骨胶、胶凝剂颗粒、增稠剂颗粒、木工粘合剂、礼盒粘合胶、木材粘合用胶、冶炼电解牛骨胶、粘性稳定牛骨胶、增稠砂轮用骨胶、墨汁用的牛骨胶、砂轮板材粘合剂、明胶木板胶粘剂
- 主营：酶cγ链、α2巨球、素d合成、纤连蛋白、抗组蛋白、蛋白样环、敏感蛋白、蛋白重链、乳球蛋白、蛋白激酶、钙调蛋白、肌醇抗体、牛骨钙素、金属肽酶、钩端螺旋、高血糖素、小鼠α1抗、ELISA试剂盒、pcr检测试剂、生化检测试剂
- 主营：共济失调蛋白3、elisa试剂盒
- 主营：ELISA试剂盒、试剂盒
- 主营：共济失调蛋白3试剂盒、elisa试剂盒
- 主营：elisa试剂盒、生化试剂盒、PCR试剂盒、人共济失调蛋白3、检测试剂盒、科研试剂盒
- 主营：人共济失调蛋白、elisa 试剂盒
- 主营：elisa试剂盒、检测试剂盒、酶免试剂盒、通蔚生物试剂盒、elisakit
- 主营：试剂盒、辅激活因子、elisa试剂盒、蛋白、多肽、金标试剂盒、PCR试剂盒、抗生素、氨基酸、血清、抗体
- 主营：人共济失调蛋白3、检测试剂盒、elisa试剂盒
- 主营：共济失调蛋白、elisa试剂盒、分子生物学试剂及试剂盒、各种抗体及免疫学试剂盒
- 主营：试剂盒、胆固醇、褪黑素、脂蛋白、源蛋白、蛋白酶、同源盒、磷酸酶、信号素、整合素、鹦鹉衣、脂肪酶、类固醇、氧化酶、中段肽、羟化酶、凝集素、白三烯、松弛肽、催乳素、肌酸受、白介素、质激素
- 主营：elisa试剂盒、检测试剂盒、PCR试剂盒
- 主营：ELISA试剂盒、抗体、细胞、共济失调蛋白3、PCR试剂盒
- 主营：Elisa试剂盒、生化试剂盒、Pcr试剂盒、共济失调蛋白、细胞、抗体
- 主营：elisa试剂盒、生化试剂盒、pcr检测试剂盒、共济失调蛋白3、细胞